Yea that about summarizes it.....funny So Innovatix and Armada are the GPO fronts for your biosimilar project with some underground wholesaler work....... Avoid the SPP all together....smart move.....I mean the pricing is not that far off the brand bio GPO's.....hahahahahaha Thats funny
Sandoz is betting that they can use the secondary business contracts they have to run claims. Novartis/Sandoz likes to do deals and run business through these smaller players because they will help drive there business. They have a history and pending legal litigation to prove it!